Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients.
Ehrenreich H, Kästner A, Weissenborn K, Streeter J, Sperling S, Wang KK, Worthmann H, Hayes RL, von Ahsen N, Kastrup A, Jeromin A, Herrmann M.
Ehrenreich H, et al. Among authors: wang kk.
Mol Med. 2011;17(11-12):1306-10. doi: 10.2119/molmed.2011.00259. Epub 2011 Sep 2.
Mol Med. 2011.
PMID: 21912808
Free PMC article.
Clinical Trial.